EFFECTIVENESS AND SAFETY OF SECOND-LINE THERAPY IN PRIMARY BILIARY CHOLANGITIS (PBC): A PROSPECTIVE MULTICENTER REAL-WORLD COHORT

被引：0

作者：

Gomez-Dominguez, Elena ^{[1
]}

Montero, Jose-Luis ^{[2
]}

Molina, Esther ^{[3
]}

Casado, Marta

Garcia-Buey, Maria Luisa ^{[4
]}

Simon, Miguel Angel ^{[5
]}

Fuentes, Javier ^{[6
]}

Diaz-Gonzalez, Alvaro ^{[7
]}

Berenguer, Marina ^{[8
]}

Conde, Isabel ^{[9
]}

Garrido, Isabel ^{[10
]}

Macedo, Guilherme ^{[10
]}

Jorquera, Francisco ^{[11
]}

Morillas, Rosa Maria ^{[12
]}

Presa, Jose Antonio ^{[13
]}

Rodriguez-Tajes, Sergio ^{[14
]}

Olivas, Ignasi ^{[15
]}

Londono, Maria Carlota ^{[14
]}

Ampuero, Javier ^{[16
,17
]}

Romero-Gonzalez, Eva ^{[18
]}

Gonzalez-Padilla, Sheila ^{[18
]}

Escudero-Garcia, Desamparados ^{[18
]}

Martin, Jose Manuel Sousa

Gomes, Dario Lorga ^{[19
]}

Santos, Luis

Olveria, Antonio ^{[20
]}

Hernandez-Guerra, Manuel ^{[21
]}

Santos, Manuel A. ^{[22
]}

Carvalho, Armando S. P.

Uriz, Juan

Gutierrez, Maria Luisa ^{[23
]}

Quinones, Marta ^{[23
]}

Perez, Elia ^{[23
]}

Martinez, Javier ^{[24
]}

Albillos, Agustin ^{[25
,26
]}

Fernandez-Rodriguez, Conrado ^{[23
,27
]}

机构：

[1] Hosp Univ 12 Octubre, Madrid, Spain

[2] Hosp Univ Reina Sofia, Cordoba, Spain

[3] Complexo Hosp Univ Santiago, Coruna, Spain

[4] Hosp Univ Princesa, Madrid, Spain

[5] Hosp Univ Lozano Blesa, Zaragoza, Spain

[6] Hosp Univ Miguel Servet, Zaragoza, Spain

[7] Hosp Univ Marques Valdecilla, Santander, Spain

[8] Univ Valencia, Hosp Univ La Fe, Valencia, Spain

[9] Hosp Univ Fe, Valencia, Spain

[10] Ctr Hosp Univ S Joao, Porto, Portugal

[11] Complejo Hosp Leon, Leon, Spain

[12] Hosp Germans Trias Pujol, Barcelona, Spain

[13] Ctr Hosp Tras Os Montes E Alto Douro, Vila Real, Portugal

[14] Hosp Clin Barcelona, Barcelona, Spain

[15] Hosp Clin Barcelona, Barcelona, Spain

[16] Virgen Rocio Univ Hosp, Seville, Spain

[17] Inst Biomed Sevilla IBIS, Seville, Spain

[18] Hosp Clin Univ Valencia, Valencia, Spain

[19] Ctr Hosp Univ Coimbra, Coimbra, Portugal

[20] Hosp Univ La Paz, Madrid, Spain

[21] Hosp Univ Canarias, Tenerife, Spain

[22] Ctr Hosp & Univ Coimbra, Coimbra, Portugal

[23] Hosp Univ Fdn Alcorcon, Madrid, Spain

[24] Hosp Univ Ramon y Cajal, Madrid, Spain

[25] Ramon y Cajal Inst Hlth Res, Madrid, Spain

[26] Univ Alcala Henares, Madrid, Spain

[27] Univ Rey Juan Carlos, Madrid, Spain

来源：

HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

116

引用

页码：S116 / S117

页数：2

共 50 条

[31] Primary biliary cholangitis-response criteria of first-line treatment and perspectives of second-line therapy
Steinmann, Silja
Schramm, Christoph
INNERE MEDIZIN, 2024, 65 (04): : 340 - 346
[32] Obeticholic acid as adjunctive therapy in Primary Biliary Cholangitis: A review of early real-world experience
Roberts, Surain
Ismail, Marwa
Kanagalingam, Gowthami
Mason, Andrew L.
Swain, Mark G.
Vincent, Catherine
Yoshida, Eric
Tsien, Cynthia
Flemming, Jennifer
Janssen, Harry
Hirschfield, Gideon
Hansen, Bettina
Gulamhusein, Aliya
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E409 - E409
[33] Real world effectiveness of Obeticholic Acid in the treatment of Primary Biliary Cholangitis
Ayyagari, Asha
Ankoma-Sey, Victor
Egwim, Chukwuma I.
Vaquerano, Laura B.
Pham, Julie
Nazario, Hector E.
Doan, Elena I.
Proffitt, Melanie
Gonzalez, Stevan A.
Modi, Apurva A.
HEPATOLOGY, 2017, 66 : 202A - 202A
[34] Real-world experience with obeticholic acid in patients with primary biliary cholangitis
D'Amato, Daphne
De Vincentis, Antonio
Malinverno, Federica
Vigano, Mauro
Alvaro, Domenico
Pompili, Maurizio
Picciotto, Antonino
Palitti, Valeria Pace
Russello, Maurizio
Storato, Silvia
Pigozzi, Marie Graciella
Calvaruso, Vincenza
De Gasperi, Elisabetta
Lleo, Ana
Castellaneta, Antonino
Pellicelli, Adriano
Cazzagon, Nora
Floreani, Annarosa
Muratori, Luigi
Fagiuoli, Stefano
Niro, Grazia Anna
Feletti, Valentina
Cozzolongo, Raffaele
Terreni, Natalia
Marzioni, Marco
Pellicano, Rinaldo
Pozzoni, Pietro
Baiocchi, Leonardo
Chessa, Luchino
Rosina, Floriano
Bertino, Gaetano
Vinci, Maria
Morgando, Anna
Vanni, Ester
Scifo, Gaetano
Sacco, Rodolfo
D'Anto, Maria
Bellia, Valentina
Boldizzoni, Roberto
Casella, Silvia
Omazzi, Barbara
Poggi, Guido
Cristoferi, Laura
Gerussi, Alessio
Ronca, Vincenzo
Venere, Rosanna
Ponziani, Francesca
Cannavo, Maria
Mussetto, Alessandro
Fontana, Rosanna
JHEP REPORTS, 2021, 3 (02)
[35] Efficacy and safety of regorafenib alone or in combinations in the second-line setting for advanced hepatocellular carcinoma: A multicenter real-world study.
Zhang, Wei
Zhao, Yanrong
Ma, Guixiang
Zhang, Yu
Guo, Yuan
Chen, Zhong
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[36] THE EFFECTIVE USE OF BEZAFIBRATE AS A SECOND LINE THERAPY FOR PRIMARY BILIARY CHOLANGITIS
Howden, Adam
Valliani, Talal
GUT, 2021, 70 : A21 - A22
[37] New Guidelines on primary biliary Cholangitis: Obeticholic Acid (Ocaliva®) considered as the only approved Second-line Therapy
不详
VISCERAL MEDICINE, 2017, 33 (05) : 392 - 392
[38] IMPACT OF SECOND-LINE THERAPIES ON QUALITY OF LIFE IN PRIMARY BILIARY CHOLANGITIS: A RETROSPECTIVE ANALYSIS
Mancinelli, M.
Bellagamba, A.
Balducci, D.
Marzioni, M.
Benedetti, A.
Maroni, L.
DIGESTIVE AND LIVER DISEASE, 2024, 56 : S155 - S156
[39] Real-World Clinical Management of Patients with Primary Biliary Cholangitis-A Retrospective Multicenter Study from Germany
Wilde, Anne-Christin Beatrice
Lieb, Charlotte
Leicht, Elise
Greverath, Lena Maria
Steinhagen, Lara Marleen
Wald de Chamorro, Nina
Petersen, Joerg
Hofmann, Wolf Peter
Hinrichsen, Holger
Heyne, Renate
Berg, Thomas
Naumann, Uwe
Schwenzer, Jeannette
Vermehren, Johannes
Geier, Andreas
Tacke, Frank
Mueller, Tobias
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (05) : 1 - 12
[40] Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada
Dai, Wei Fang
Beca, Jaclyn M.
Croxford, Ruth
Isaranawatchai, Wanrudee
Menjak, Ines B.
Petrella, Teresa M.
Mittmann, Nicole
Earle, Craig C.
Gavura, Scott
Hanna, Timothy P.
Chan, Kelvin K. W.
BMC CANCER, 2020, 20 (01)

← 1 2 3 4 5 →